S D Rabkin - JoVE Visualize

Showing results (51-60 of 63) with videos related to

Pageof 7

Sort By:

Journal of Neuro-Oncology|January 1, 1995

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470T Yazaki, Y Takamiya, P C Costello, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994

Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vectorM G Kaplitt, A D Kwong, S P Kleopoulos, et al.

Human Gene Therapy|June 2, 2001

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primatesS Varghese, J T Newsome, S D Rabkin, et al.

Brain Research. Molecular Brain Research|October 1, 1994

Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cellsJ Verhaagen, W T Hermens, A B Oestreicher, et al.

Molecular Pharmacology|August 1, 1996

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.

Gene Therapy|March 12, 2010

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancerP Castelo-Branco, B J Passer, J S Buhrman, et al.

Gene Therapy|May 15, 2009

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effectD Kolodkin-Gal, Y Edden, Z Hartshtark, et al.

Experimental Neurology|April 21, 2001

Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor modelG A Mashour, H D Moulding, A Chahlavi, et al.

Gene Therapy|September 7, 1999

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivoS I Miyatake, S Tani, F Feigenbaum, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotusT Todo, F Feigenbaum, S D Rabkin, et al.

Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:

Pageof 7

Journal of Neuro-Oncology|January 1, 1995

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470T Yazaki, Y Takamiya, P C Costello, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994

Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vectorM G Kaplitt, A D Kwong, S P Kleopoulos, et al.

Human Gene Therapy|June 2, 2001

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primatesS Varghese, J T Newsome, S D Rabkin, et al.

Brain Research. Molecular Brain Research|October 1, 1994

Expression of the growth-associated protein B-50/GAP43 via a defective herpes-simplex virus vector results in profound morphological changes in non-neuronal cellsJ Verhaagen, W T Hermens, A B Oestreicher, et al.

Molecular Pharmacology|August 1, 1996

Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotideT Yazaki, S Ahmad, A Chahlavi, et al.

Gene Therapy|March 12, 2010

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancerP Castelo-Branco, B J Passer, J S Buhrman, et al.

Gene Therapy|May 15, 2009

Herpes simplex virus delivery to orthotopic rectal carcinoma results in an efficient and selective antitumor effectD Kolodkin-Gal, Y Edden, Z Hartshtark, et al.

Experimental Neurology|April 21, 2001

Therapeutic efficacy of G207 in a novel peripheral nerve sheath tumor modelG A Mashour, H D Moulding, A Chahlavi, et al.

Gene Therapy|September 7, 1999

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivoS I Miyatake, S Tani, F Feigenbaum, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2000

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotusT Todo, F Feigenbaum, S D Rabkin, et al.

Pageof 7